TransCode Therapeutics Inc. Common Stock is a leading biotechnology company that focuses on developing innovative RNA-based therapeutics. With a strong pipeline of promising candidates, the company is dedicated to revolutionizing the treatment of diseases by targeting specific genes and gene mutations. Their cutting-edge technologies and research efforts have the potential to significantly impact the future of medicine.
